Survivorship in Early-Stage Rectal Cancer Patients Who Have Received Combined Modality Therapy
Clinical Colorectal Cancer · 2023
DOI: 10.1016/j.clcc.2023.08.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Colorectal Cancer, 2023. Verfasst von Saboor E Randhawa und 1 weiteren Autor:innen. Beteiligte Einrichtung: Hematology and Medical Oncology Fellow, University of Nebraska Medical Center, Omaha, NE. Hauptthemen laut MEDLINE: Rectal Neoplasms, Cancer Survivors. Die Arbeit nennt 92 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Survival rates in early-stage rectal cancer patients have increased over the past few decades. Societies such as the National Comprehensive Cancer Network (NCCN), American Cancer Society (ACS), American Society of Clinical Oncology (ASCO), and European Society of Medical Oncology (ESMO) have proposed guidelines related to cancer survivorship care including formal recommendations to address the needs in early-stage rectal cancer survivors. These guidelines, in addition to new clinical research findings in survivorship will be reviewed, specifically looking at physical, psychosocial, and financial concerns in rectal cancer survivorship.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hematology and Medical Oncology Fellow, University of Nebraska Medical Center, Omaha, NE.
- Department of Gastrointestinal Oncology, University of Nebraska Medical Center, Omaha, NE. Electronic address: ltenner@unmc.edu.
Zitieren
APA
Randhawa, S. E., & Tenner, L. (2023). Survivorship in Early-Stage Rectal Cancer Patients Who Have Received Combined Modality Therapy. Clinical Colorectal Cancer. https://doi.org/10.1016/j.clcc.2023.08.002
Vancouver
Randhawa SE, Tenner L. Survivorship in Early-Stage Rectal Cancer Patients Who Have Received Combined Modality Therapy. Clinical Colorectal Cancer. 2023. doi:10.1016/j.clcc.2023.08.002
BibTeX
@article{Randhawa2023,
author = {Randhawa, Saboor E and Tenner, Laura},
title = {Survivorship in Early-Stage Rectal Cancer Patients Who Have Received Combined Modality Therapy},
journal = {Clinical Colorectal Cancer},
year = {2023},
doi = {10.1016/j.clcc.2023.08.002}
}
EUVIMED